Joseph C. Sardano is CEO at Sensus Healthcare, Inc. (SRTS). They have made 14 open-market trades across 1 company since 2016, most recently 2026-08-20.
CIK 0001300111
5 open-market purchases totalling $355K since 2023, against 9 sales. Across 5 scored buys the stock is down 11.1% at thirty days, and 11.6 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| SRTS | 1,220,293 | $3.4M |
Shares reported on the most recent Form 4, priced at the 2026-08-24 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 20% | — |
| Avg Move | -6.8% | -11.1% | — |
| Alpha | -6.0% | -11.6% | — |
| Scored | 5 | 5 | 4 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SRTS | BUY | 2026-08-20 | 2026-08-24 | $3.02 | $60K | -5.0% | -11.1% | — |
| SRTS | BUY | 2025-11-18 | 2025-11-19 | $4.03 | $101K | -2.2% | -7.7% | -7.7% |
| SRTS | BUY | 2023-09-14 | 2023-09-18 | $2.88 | $29K | -5.0% | -12.2% | -11.8% |
| SRTS | BUY | 2023-08-08 | 2023-08-08 | $3.86 | $39K | -20.7% | -26.0% | -42.9% |
| SRTS | BUY | 2023-05-09 | 2023-05-11 | $2.99 | $126K | -1.0% | +1.7% | +30.0% |
| SRTS | SELL | 2022-09-02 | 2022-09-07 | $12.55 | $918K | +10.1% | -4.6% | -48.3% |
| SRTS | SELL | 2022-08-09 | 2022-08-11 | $14.13 | $4.5M | -8.0% | -3.9% | -46.7% |
| SRTS | SELL | 2022-03-09 | 2022-03-11 | $10.16 | $2.3M | +9.8% | -13.4% | -15.4% |
| SRTS | SELL | 2021-12-15 | 2021-12-17 | $7.00 | $339K | -1.9% | +12.2% | +40.3% |
| SRTS | SELL | 2021-12-13 | 2021-12-16 | $7.19 | $234K | +1.8% | +20.4% | +51.7% |
| SRTS | SELL | 2021-12-09 | 2021-12-13 | $7.79 | $501K | +22.3% | +29.0% | +45.0% |
| SRTS | SELL · 10b5-1 | 2018-09-10 | 2018-09-12 | $7.54 | $22K | +10.6% | +3.9% | -17.0% |
| SRTS | SELL · 10b5-1 | 2018-08-28 | 2018-08-30 | $7.50 | $11K | +3.7% | +16.4% | -21.9% |
| SRTS | SELL · 10b5-1 | 2018-08-08 | 2018-08-10 | $7.50 | $46K | -3.5% | +3.1% | -9.4% |
| SRTS | SELL · 10b5-1 | 2018-08-02 | 2018-08-06 | $7.50 | $3K | +0.4% | +2.3% | -13.7% |
| SRTS | SELL · 10b5-1 | 2018-06-26 | 2018-06-28 | $7.50 | $6K | +7.5% | -1.3% | +15.8% |
| SRTS | SELL | 2018-06-21 | 2018-06-25 | $7.52 | $200K | -2.4% | -10.7% | +1.6% |
| SRTS | SELL | 2018-06-18 | 2018-06-20 | $7.53 | $293K | -0.8% | -7.7% | -8.0% |
| SRTS | SELL · 10b5-1 | 2017-10-27 | 2017-10-31 | $6.00 | $42K | -0.7% | -8.2% | -3.1% |
| SRTS | SELL · 10b5-1 | 2017-09-13 | 2017-09-19 | $6.00 | $21K | -5.9% | +8.7% | -5.3% |
| SRTS | SELL · 10b5-1 | 2017-09-07 | 2017-09-13 | $6.00 | $73K | -19.2% | -4.2% | -14.1% |
| SRTS | SELL | 2017-09-05 | 2017-09-06 | $6.00 | $80K | -11.7% | -10.2% | -10.0% |
| SRTS | SELL · 10b5-1 | 2017-08-25 | 2017-08-29 | $6.00 | $58K | +3.8% | -12.5% | -5.4% |
| SRTS | SELL · 10b5-1 | 2017-08-23 | 2017-08-25 | $6.00 | $49K | +0.0% | -20.0% | -7.0% |
| SRTS | SELL · 10b5-1 | 2016-12-01 | 2016-12-05 | $6.00 | $2K | -4.3% | -14.7% | -23.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.